Amoxicillin

For an informed discussion with your doctor or pharmacist. This information collection is not a clinically validated interaction checker. Missing data do not establish safety. Do not change or stop prescribed medicines on the basis of this information. The findings apply to the specific conditions studied; laboratory and animal studies cannot be directly extrapolated to humans.

Active substance: Amoxicillin

Examples of brand names: Amoxypen [DE]

ATC code: J01CA04

Main use (for orientation): Bacterial infections

Documented research summary

No sufficiently attributable cannabinoid–amoxicillin pair is substantiated within the documented search scope. The structured assessment distinguishes supported drug context from missing specific interaction evidence. Missing data do not establish safety.

Uncertainties and limitations

Do not equate with amoxicillin/clavulanic acid; substance mixtures and infectious consequences do not substantiate a pair finding. Do not infer independent changes to prescribed medicines from this research dataset.

Structured assessment

Category: Drug context

Cannabinoid scope: No specifically substantiated pair involving a registered cannabinoid in the material assessed; no claim that all 28 cannabinoids were comprehensively reviewed simultaneously.

Evidence status: Drug properties supported by product information; insufficient evidence for a specific cannabinoid–drug pair effect.

Mechanism / drug context: Substantial unchanged renal elimination; oral amoxicillin as a single active substance here.

Type of supporting material: Product information and documented individual literature screening; no clinical pair trial approved for use as evidence.

Clinical interpretation: No established cannabinoid-related change in exposure or loss of effect.

Context: The selected information concerns oral amoxicillin without clavulanic acid; the combination has a different medicine profile.

Drug context and gaps in search results are not measured interactions. The source role below describes which statement the source actually supports.

Source role [VE_LABEL_D0282]: Original product information: drug context, not evidence for a cannabinoid–drug pair

Statement supported: Substantial unchanged renal elimination; oral amoxicillin as a single active substance here.

Source: AMOXICILLIN CAPSULE [REMEDYREPACK INC.] [VE_LABEL_D0282]

Scope of review: Individual research with documented title/abstract screening and targeted review of original sections. This is not exhaustive evidence that interactions are absent.

Unresolved source question: All individual review fields read. Original product information rechecked only in the relevant pharmacokinetic / interaction excerpts; not a complete recertification of all labels or a worldwide full-text search. Literature access through the pre-existing documented screening; only the listed web sources were additionally read in this round. Do not equate with amoxicillin/clavulanic acid; substance mixtures and infectious consequences do not substantiate a pair finding.

Separately recorded findings

No separately substantiated finding for this drug–cannabinoid pair is recorded within the documented scope of review. This does not prove that no such study exists anywhere or that the combination is safe.

References and access status

[VE_LABEL_D0282] AMOXICILLIN CAPSULE [REMEDYREPACK INC.]

Original source / bibliographic reference

Authors: Respective marketing authorisation holder; regulatory product information

Year: 2026

Source type: Product information / SmPC / US Prescribing Information

Source access – 23 October 2026: Source destination was accessible when checked.

Bibliographic attribution or source identity cross-checked.

Research as of 23 October 2026. Not all original full texts could be reviewed in full. Source accessibility and the strength of scientific evidence must be assessed separately. An accessible link does not establish medical approval; a bibliographic record with an abstract does not replace the original full text.

Drug search and explanation of the evidence · Guide: cannabinoids and medicines · Author and responsibility